Mealey's (May 21, 2019, 2:11 PM EDT) -- BOSTON — In a 111-page decision outlining her findings of fact and conclusions of law, a federal judge in Massachusetts on May 17 agreed with the Dana-Farber Cancer Institute that its professor should be named as a co-inventor on six immunotherapy patents (Dana-Farber Cancer Institute Inc. v. Ono Pharmaceutical Co. Ltd., et al., No. 15-13443, D. Mass., 2019 U.S. Dist. LEXIS 83375)....